Live at SynBioBeta
Each year, SynBioBeta hosts the The Global Synthetic Biology Conference to showcase the latest cutting-edge developments in biology that...
top of page
Search
Antheia
- May 12
Leveraging Synthetic Biology for Resilient Pharma Supply Chains and Accessible Medicines
Antheia's Associate Member Spotlight was originally published on the Association for Accessible Medicines blog, which can be found here...
Antheia
- Apr 26
Advancing the U.S. Bioeconomy and Building Resilient Pharmaceutical Supply Chains
We continue to see the U.S. government setting policy priorities that underscore the importance of both building a robust American...
Antheia
- Apr 25
Synthetic Chemistry in Pharma
This blog is part of an educational series about synthetic chemistry. If you missed our introductory primer, you can find it here. In...
Antheia
- Mar 2
Introducing Jesse Ahrendt, Antheia’s SVP of Quality Assurance & Regulatory Affairs
We’ve recently welcomed Jesse Ahrendt, our new Senior Vice President of Quality Assurance and Regulatory Affairs, who will lead our...
Antheia
- Feb 16
Synthetic Biology vs Synthetic Chemistry: A Primer
At Antheia, we spend a lot of time talking about synthetic biology due to the nature of our work engineering yeast to produce active...
Antheia
- Nov 20, 2022
Antheia CEO on How Biomanufacturing can De-Risk Pharmaceutical Production
In a recent Q&A with European Pharmaceutical Manufacturer Antheia CEO and co-founder Dr. Christina Smolke discussed how latency...
![Antheia CEO Presents at CPHI on Transforming Pharma Supply Chains [Watch]](https://static.wixstatic.com/media/b9c8d9_033a0c34250244f7bfb280d4acafdb1e~mv2.png/v1/fill/w_410,h_308,fp_0.50_0.50,q_95,enc_auto/b9c8d9_033a0c34250244f7bfb280d4acafdb1e~mv2.png)
Antheia
- Sep 28, 2022
Antheia CEO Presents at CPHI on Transforming Pharma Supply Chains [Watch]
Antheia CEO and co-founder Christina Smolke shared how synthetic biology can help solve pressing pharma challenges during the 2022 CPHI...
Antheia
- Aug 25, 2022
Demystifying Synthetic Biology Part V: The Product is Key in Downstream Processing
Dive into DSP in the final edition of our Demystifying SynBio series. If you’re just joining us, be sure to catch up on parts I, II, III,...
Antheia
- Aug 16, 2022
Introducing Guerin Kob, Antheia’s VP of Supply Chain
With a pilot plant on the horizon and a pipeline filled with promise, Antheia is poised to soon establish a fermentation-based supply...
Antheia
- Jul 18, 2022
Demystifying Synthetic Biology IV: Fermentation Bioprocess Development
Learn more about synbio and the tools and technologies advancing this field in Part I, Part II, and Part III of this blog series....
Antheia
- Jun 12, 2022
Demystifying Synthetic Biology III: The 21st Century Technologies Advancing Synthetic Biology
Just joining us? Check out Part I and Part II of the series. Synthetic biology is often touted as a software-driven and...
Antheia
- Jun 6, 2022
Introducing CPO Heidi Pucel
Growth and change can be challenging within dynamic, evolving startups, but it’s easier to navigate when you are tuned in to how people...
Antheia
- Apr 13, 2022
Demystifying Synthetic Biology II: Molecular Biology Advancements Enabling Synthetic Biology
Just joining us? Start with part one of our demystifying synthetic biology series. Synthetic biology seems like a brand-new, precision...
Antheia
- Feb 9, 2022
Demystifying Synthetic Biology: Building with the power of biology
Technology today is defined by superlatives: we have the fastest cars, the best medicine, and the most advanced communication tools ever...
Antheia
- Dec 10, 2021
Introducing Zack McGahey, Antheia’s COO
Antheia is at a critical point in scaling our production technology. Just as we bring together exceptional science and technologies to...
Christina Smolke
- Oct 12, 2021
Join the Movement to Build a Century-Defining Technology
Synthetic biology isn’t a household name - yet. But it will be soon, because it’s a thriving, innovative field that’s solving some of...
Antheia
- Apr 6, 2021
Fixing essential medicine shortages: obstacles and opportunities
Global health experts and governing bodies agree that everyone has a right to access the medicines they need. The COVID-19 pandemic and...
Kristy Hawkins
- Mar 22, 2021
Investing in the next wave of biomanufacturing technologies for pharma
The global pandemic has brought pharmaceutical manufacturing to the forefront of America’s public consciousness. Acute drug shortages...
Antheia
- Feb 4, 2021
Meet the Team - Our Lab Operations Team
For the final installation in our “Meet the Team” series, we hear from Olivia, Khurram and Vicky, who lead our operations. This team is...
Antheia Newsroom
bottom of page